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Ion channels play an important role during sperm capacitation allowing the transport through plasma and mitochondrial membranes of specific molecules that are essential for the achievement of this physiologic status. Given that voltage-dependent anion channel 2 (VDAC2) is present in boar spermatozoa and is known to be involved in calcium transport in somatic cells, this study aimed at determining whether it is implicated in sperm capacitation and the acrosome reaction. With this purpose, boar spermatozoa were capacitated in vitro for 4 hr, and acrosome reaction was induced with progesterone for a further hour, with or without the presence of two VDAC2-inhibitors (erastin and olesoxime) at two different concentrations (10 and 100 μM). At different time points (0, 120, 240, 270 and 300 min), an aliquot was taken and sperm motility, membrane integrity and lipid disorder were evaluated using computer-assisted sperm analysis and flow cytometry. The addition of the two inhibitors resulted in opposite effects. While erastin 100 μM reduced the percentage of non-capacitated spermatozoa, the presence of olesoxime at the same concentration prevented the increase in membrane lipid disorder, which is a feature of sperm capacitation. Such prevention was concomitant with a maintaining effect on sperm membrane integrity evaluated through SYBR14/PI. Our results suggest that VDAC2 is involved in the regulation of sperm capacitation, despite the fact that the mechanisms through which erastin and olesoxime act are different.
| INTRODUCTION
Sperm capacitation is a complex process that involves a series of molecular changes required for sperm to fertilize the oocyte. This process may be divided into two separate steps: early and fast (Visconti, 2009 ). Fast events start upon ejaculation, and late events occur after sperm release from the oviductal reservoir (Yeste, 2013) . Ion channels are involved in calcium transport in both fast and early events. Apart from CatSper channels, which have been largely studied in the literature (see Correia, Michelangeli, & Publicover, 2015 for review), mammalian sperm contain other ion channels that could also be involved in Ca 2+ transport.
Voltage-dependent Anion Channel 2 (VDAC2) promotes Ca 2+ transport to mitochondria, known to be main Ca
2+
-stores in mammalian sperm (Yeste et al., 2015) . VDAC2 has been localized in the outer mitochondrial membrane and acrosome of mammalian spermatozoa and has also been found to be related to boar sperm cryotolerance (Hinsch et al., 2004; Vilagran et al., 2014) . While previous research has demonstrated that VDAC2 is involved in the regulation of sperm motility (Liu et al., 2010) , its potential involvement with sperm capacitation is yet to be elucidated.
This study was sought to determine the involvement of VDAC2 in boar sperm capacitation. With this purpose, boar spermatozoa were subjected to in vitro capacitation and subsequent progesterone- 
| MATERIALS AND METHODS

| Reagents
Unless stated otherwise, all reagents were of biological grade and were purchased from Sigma-Aldrich (Saint-Louis, Missouri, USA).
Fluorochromes were purchased from Thermo Fisher Scientific (Waltham, Massachusetts, USA).
| Sperm samples capacitation
Fourteen semen doses coming from different boars were washed by centrifugation, first resuspended with PBS and subsequently with TALP medium containing: 4.77 mg/ml Hepes, 6.55 mg/ml sodium chloride, 0.23 mg/ml sodium chloride, 0.66 mg/ml calcium chloride, 0.90 mg/ml glucose, 0.10 mg/ml magnesium sulphate, 5 mM sodium bicarbonate, 0.11 mg/ml sodium pyruvate, 2.43 mg/ml l-lactate and 4.84 mg/ml bovine serum albumin (pH adjusted to 7.4). Sperm capacitation was performed at 38.5°C and 5% CO 2 for 240 min, when acrosome exocytosis was induced through the addition of progesterone (10 μg/ml). Samples were evaluated at 0, 120, 240, 270 and 300 min.
| Inhibitors: erastin and olesoxime
Following the preliminary experiments when both inhibitors (erastin, E and olesoxime, O, also known as TRO19622) were tested at a logscale, two concentrations were set as follows: 10 μM (E10, O10) and 100 μM (E100, O100).
| Flow cytometry
Sperm viability and membrane lipid disorder (a marker of sperm capacitation) were determined by flow cytometry (Cell laboratory QuantaSC ™ ; Beckman Coulter; Fullerton, California, USA). Sperm viability was determined using a commercial kit (LIVE/DEAD ® Kit containing SYBR14 and propidium iodide, PI) and membrane lipid disorder with merocyanine 540 (M540) and YO-PRO-1, as described by Yeste et al. (2013) . In all cases, three replicates per sample were assessed, and 10,000 events were evaluated per replicate.
| Evaluation of sperm motility
Sperm motility was determined with a computer-assisted sperm analysis system (ISAS; PROISER, Valencia, Spain), using a phase-contrast microscope (Olympus BX41; Olympus Europe GmbH, Hamburg, Germany). Three counts of at least 1,000 spermatozoa each were determined per sample.
| Statistical analyses
Results were analysed with a statistical package (IBM SPSS 21.0;
Chicago, Illinois, USA). Data were first checked for normality and homoscedasticity. The effects of treatment (control, E10, E100, O10
and O100) and the incubation time (0, 120, 240, 270 and 300 min) were determined with a linear mixed model followed by post hoc Sidak test. Significance level was at set p ≤ .05, and results are shown as mean ± standard error of the mean (SEM).
| RESULTS
| Sperm motility
Percentages of total and progressively motile spermatozoa are shown in Figures 1 and 2 . Overall, there was a reduction in both total and progressive sperm motility over incubation time. Interestingly, F I G U R E 1 Percentages of total motile spermatozoa (mean ± SEM) over the incubation period. Different superscript letters indicate significant (p ≤ .05) differences between treatments with a give time point. E10: erastin 10 μM; E100: erastin 100 μM; O10: olesoxime 10 μM; O100: olesoxime 100 μM [Colour figure can be viewed at wileyonlinelibrary.com] F I G U R E 2 Percentages of progressively motile spermatozoa (mean ± SEM) over the incubation period. Different superscript letters indicate significant (p ≤ .05) differences between treatments with a give time point. E10: erastin 10 μM; E100: erastin 100 μM; O10: olesoxime 10 μM; O100: olesoxime 100 μM [Colour figure can be viewed at wileyonlinelibrary.com] olesoxime at 10 μM (O10) increased the percentage of total and progressively motile spermatozoa at 120 min, whereas the addition of erastin at the highest concentration (100 μM, E100) significantly decreased those percentages. At the end of the experiment, percentages of total and progressively motile spermatozoa in the treatments containing erastin (E10 and E100) were significantly (p < .05) lower than the control.
| Sperm viability
Percentages of viable spermatozoa (SYBR14 + /PI − ) significantly (p < .05) decreased in the control and all treatments over the incubation time, except for the case of O100 (100 μM), which showed a higher percentage of viable spermatozoa than the other treatments (p < .05). In contrast, percentages of viable spermatozoa in E100 were lower than the control (p < .05) from 120 min and until the end of the experiment (Figure 3 ). 
| Membrane lipid disorder
| DISCUSSION
The current study evaluated how the addition of specific VDAC2-inhibitors (erastin and olesoxime) at two different concentrations (10 and 100 μM) affected in vitro capacitation and subsequent acrosome exocytosis in boar spermatozoa. On one hand, our data showed that the addition of olesoxime did not affect much sperm motility, apart from the higher percentage of total motile spermatozoa at 120 and 240 min in O10. In contrast, the presence of erastin, especially at the highest concentration, reduced the sperm motility.
On the other hand, the analysis of sperm viability and membrane lipid disorder indicated that olesoxime at 100 μM inhibited sperm capacitation. This inhibitory effect suggests that VDAC2 plays a vital role in the regulation mitochondrial Ca 2+ transport which is crucial for sperm capacitation (Correia et al., 2015) . However, the most interesting results come from the comparison between the two inhibitors.
Indeed, while both inhibitors have been reported to inhibit VDAC2, their effects on sperm motility, and especially viability and membrane lipid disorder differ. Thus, whereas the increase in the membrane lipid disorder, which is a feature of sperm capacitation, is also observed in E100, the addition of olesoxime at 100 μM inhibits this increment, so not only do those sperm cells remain viable (SYBR14 + /PI − ), but also their membrane lipid disorder is low.
Our data suggest that both inhibitors could act through separate pathways. It is worth noting that erastin triggers ferroptosis in somatic cells, but this pathway has not been identified in mammalian spermatozoa (Yagoda et al., 2007) . Furthermore, olesoxime is a neuroprotective drug that is used in neurological diseases, such as amyotrophic lateral sclerosis (Bordet et al., 2010) , so that further studies are required to address why this molecule has positive effects upon sperm viability under capacitating conditions. Finally, differences in the structure of these ; mean ± SEM) over the incubation period. Different superscript letters indicate significant (p ≤ .05) differences between treatments with a give time point. E10: erastin 10 μM; E100: erastin 100 μM; O10: olesoxime 10 μM; O100: olesoxime 100 μM [Colour figure can be viewed at wileyonlinelibrary. com] two inhibitors could underlie different abilities of these molecules to bind VDAC2 which could, in turn, explain their separate effects.
In summary, this study has demonstrated that blocking VDAC2 affects sperm capacitation. However, further research is required to address why the two inhibitors used in this study exert different effects.
